Popular topics to explore

★All TopicsEquity ResearchFundamental ViewsHidden GemsIndex StrategiesIPOMacro ViewsMiscellaneousPersonal FinancePost-Closing CommentaryPre-Opening CommentaryPsychology of MoneySector BreakoutStock In NewsTechnical ViewsTime To ExitToday's Trading SetupTrending SectorsWatch Out For
‹ All Posts
Mayank Kumar
Mayank Kumar

12th Jul 2025 · SEBI-Registered Analyst

Glenmark

GLENMARK
Glenmark: Company Subsidiary IGI has signed a $ 700 million global licensing deal with AbbVie for its oncology asset ISB 2001. (Positive)

#FundamentalViews#TechnicalViews
GLENMARK_2025-07-12_06-32-19.png
537 likes·19 comments